Home > Insider Trading > Filing (0001209191-22-027202)

Filing Details

Accession Number:: 0001209191-22-027202
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-05-04 17:52:43
Reporting Period:: 2022-05-02

Accepted Time:: 2022-05-04 17:52:43
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
860730	Hca Healthcare Inc.	HCA	Services-General Medical & Surgical Hospitals, Nec (8062)	273865930

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
900596	Jr F Thomas Frist	3100 West End Avenue Nashville TN 37203		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock, Par Value $0.01 Per Share	Acquisiton	2022-05-02	4,128	$209.73	393,983	No	4	P	Direct
Common Stock, Par Value $0.01 Per Share	Acquisiton	2022-05-02	37,623	$210.60	431,606	No	4	P	Direct
Common Stock, Par Value $0.01 Per Share	Acquisiton	2022-05-02	16,313	$211.22	447,919	No	4	P	Direct
Common Stock, Par Value $0.01 Per Share	Acquisiton	2022-05-02	3,606	$212.60	451,525	No	4	P	Direct
Common Stock, Par Value $0.01 Per Share	Acquisiton	2022-05-02	7,683	$213.47	459,208	No	4	P	Direct
Common Stock, Par Value $0.01 Per Share	Acquisiton	2022-05-02	12,170	$214.48	471,378	No	4	P	Direct
Common Stock, Par Value $0.01 Per Share	Acquisiton	2022-05-02	7,577	$215.29	478,955	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock, Par Value $0.01 Per Share	307,936	Indirect	Held indirectly through Hercules Holding II
Common Stock, Par Value $0.01 Per Share	72,589	Indirect	Held indirectly through Hercules Holding II by Thomas F. Frist GST Tax Exempt Trust
Common Stock, Par Value $0.01 Per Share	232,395	Indirect	Held indirectly through Hercules Holding II by Patricia Champion Frist 2020 GRAT
Common Stock, Par Value $0.01 Per Share	36,629,164	Indirect	Held indirectly through Hercules Holding II by Frisco, Inc.

Footnotes

The price reported in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $209.40 to $209.97, inclusive. The Reporting Person undertakes to provide HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
The price reported in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $210.00 to $210.99, inclusive. The Reporting Person undertakes to provide HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
The price reported in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $211.00 to $211.89, inclusive. The Reporting Person undertakes to provide HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
The price reported in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $212.06 to $212.97, inclusive. The Reporting Person undertakes to provide HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
The price reported in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $213.02 to $213.98, inclusive. The Reporting Person undertakes to provide HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
The price reported in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $214.00 to $214.97, inclusive. The Reporting Person undertakes to provide HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
The price reported in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $215.05 to $215.71, inclusive. The Reporting Person undertakes to provide HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Hercules Holding II ("Hercules") holds 68,912,077 shares of common stock of HCA Healthcare, Inc. Hercules is held by a private investor group, including affiliates of HCA Inc. founder Dr. Thomas F. Frist Jr. The Reporting Person may be deemed to be a member of a group exercising voting and investment control over the shares of common stock of HCA Healthcare, Inc. held by Hercules. However, the Reporting Person disclaims membership in any such group and disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein.
The Reporting Person directly owns 307,936.079368 units of Hercules and therefore may be deemed to own indirectly the same number of shares of common stock of HCA Healthcare, Inc. by virtue of his ownership in Hercules.
The Reporting Person is trustee of (i) the Thomas F. Frist GST Tax Exempt Trust and (ii) the Patricia Champion Frist 2020 Grantor Retained Annuity Trust and may be deemed to be the beneficial owner of the units of Hercules held by these trusts and therefore may be deemed to own indirectly the same number of shares of common stock of HCA Healthcare, Inc.
The Reporting Person may be deemed to share voting and dispositive power with respect to 36,629,163.8593 shares of HCA Healthcare, Inc. beneficially owned by Frisco, Inc., by virtue of his position as a director of Frisco, Inc. Frisco, Inc. has beneficial ownership of 36,629,163.8593 units of Hercules, and therefore may be deemed to own indirectly the same number of shares of common stock of HCA Healthcare, Inc.